Assessment of occupational exposure to malathion and bifenthrin in mosquito control sprayers through dermal contact.

OBJECTIVE: To assess occupational exposure of malathion and bifenthrin concentrations by dermal contact and urinary 3-(2-chloro-3, 3, 3-trifluoro-1-propenyl)-2, 2-dimethyl-cyclopropanecarboxylic (TFP) acid, health symptoms developed and the relationship between bifenthrin concentrations and TFP acid in urine of the mosquito control sprayers. MATERIAL AND METHOD: The aerosols of these two pesticides were collected using 100 cm2 cotton patches attached on the skin of upper legs of 54 volunteer of mosquito control sprayers. Their urine samples were also collected before and after application. RESULTS: These subjects exposed to average malathion and bifenthrin concentrations of 0.18 and 0.32 microg/cm2, respectively After application, the average concentration of urinary TFP acid in the sprayers was 39.22 +/- 0.77 mg/g creatinine ranging from 0.58 to 261.19 mg/g creatinine. A significant difference was found between urinary TFP acid levels before and after application (p < 0.001) but the bifenthrin concentrations through dermal contact and urinary TFP acid levels were not significantly correlated (p > 0.05). CONCLUSION: The mosquito control sprayers had dermal contact with smoke of malathion and bifenthrin and some sprayers developed health symptoms after exposure. They should use protective clothing made ofplastic, nylon or polyester to protect sprayers from skin contact.

Exposure to trinitrotoluene and health effects among workers in an artillery and ammunition plant.

OBJECTIVE: To determine urinary trinitrotoluene (TNT), 2-amino-4, 6-dinitrotoluene (2ADNT) and 4-amino-2, 6-dinitrotoluene (4ADNT) and health effects upon workers in an ammunition plant. MATERIAL AND METHOD: The urine samples from forty munition workers and forty office workers were monitored for TNT and its metabolites by gas chromatography-mass spectrometry. The workers were interviewed with a questionnaire. RESULTS: The median levels of TNT and its metabolites were 112.84 and ranged from non-detectable (ND) to 1,833.81 mg/L. Median levels for 2ADNT were 11.66, ranging from ND to 360.89 mg/L. Median levels for 4ADNT were 19.95 and ranged from ND to 314.28 mg/L. There were significant correlations between TNT and 2ADNT in urine (r = 0. 700, p-value < 0.001), as well as for TNT and 4ADNT (r = 0.783, p-value < 0.001). Exposed workers reported eye, nose and throat irritations, weakness and headaches with considerably higher frequency than non-exposed workers. CONCLUSION: TNT levels in urine were strongly associated with 4ADNT and 2ADNT levels. Workers exposed to TNT complained of nose, throat and eye irritation, along with overall weakness and headaches.